These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3094 related items for PubMed ID: 17803471

  • 41. Clinical manifestations of systemic lupus erythematosus, measures of disease activity, and long-term complications.
    Ginzler EM, Antoniadis I.
    Curr Opin Rheumatol; 1992 Oct; 4(5):672-80. PubMed ID: 1419501
    [Abstract] [Full Text] [Related]

  • 42. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
    Bruce IN, Hallett DC, Gladman DD, Urowitz MB.
    J Rheumatol; 1999 Jul; 26(7):1490-4. PubMed ID: 10405935
    [Abstract] [Full Text] [Related]

  • 43. [Long-term outcome of paediatric lupus nephritis].
    Casado Picón R, Lumbreras Fernández J, Muley Alonso R, Vara Martín J.
    An Pediatr (Barc); 2010 May; 72(5):317-23. PubMed ID: 20392678
    [Abstract] [Full Text] [Related]

  • 44. [Prognostic factors in children with lupus nephritis].
    Wikiera-Magott I, Medyńska A, Zwolińska D.
    Wiad Lek; 2005 May; 58 Suppl 1():50-4. PubMed ID: 16060085
    [Abstract] [Full Text] [Related]

  • 45. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C, Randhawa H, Reeve R, Waldek S, Wood GN, O'Donoghue DJ, Kalra PA.
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [Abstract] [Full Text] [Related]

  • 46. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature.
    Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M.
    Q J Med; 1989 Sep; 72(269):779-833. PubMed ID: 2694209
    [Abstract] [Full Text] [Related]

  • 47. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Lisitsyna TA, Nasonov EL.
    Klin Med (Mosk); 2004 Sep; 82(6):46-51. PubMed ID: 15344691
    [Abstract] [Full Text] [Related]

  • 48. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 49. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
    Vu TV, Escalante A.
    J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
    [Abstract] [Full Text] [Related]

  • 50. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED.
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [Abstract] [Full Text] [Related]

  • 51. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI, Feldman BM, Bombardier C, Silverman ED.
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [Abstract] [Full Text] [Related]

  • 52. Intravenous cyclophosphamide for lupus nephritis in Thai children.
    Vachvanichsanong P, Dissaneewate P, Winn T.
    Scand J Rheumatol; 2004 Jul; 33(5):339-42. PubMed ID: 15513684
    [Abstract] [Full Text] [Related]

  • 53. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome].
    Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Kushnir VV, Shakhnova EA, Miroshnichenko NG, Serova AG, Nesterova SG.
    Ter Arkh; 2007 Jul; 79(6):16-25. PubMed ID: 17684961
    [Abstract] [Full Text] [Related]

  • 54. Renal involvement in primary antiphospholipid syndrome.
    Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA.
    J Rheumatol; 1992 Aug; 19(8):1181-5. PubMed ID: 1404151
    [Abstract] [Full Text] [Related]

  • 55. The outcome of renal transplantation among systemic lupus erythematosus patients.
    Chelamcharla M, Javaid B, Baird BC, Goldfarb-Rumyantzev AS.
    Nephrol Dial Transplant; 2007 Dec; 22(12):3623-30. PubMed ID: 17640941
    [Abstract] [Full Text] [Related]

  • 56. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 57. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM.
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [Abstract] [Full Text] [Related]

  • 58. Autonomic dysfunction in patients with systemic lupus erythematosus.
    Gamez-Nava JI, Gonzalez-Lopez L, Ramos-Remus C, Fonseca-Gomez MM, Cardona-Muñoz EG, Suarez-Almazor ME.
    J Rheumatol; 1998 Jun; 25(6):1092-6. PubMed ID: 9632069
    [Abstract] [Full Text] [Related]

  • 59. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
    Nery FG, Borba EF, Viana VS, Hatch JP, Soares JC, Bonfá E, Neto FL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):695-700. PubMed ID: 18077068
    [Abstract] [Full Text] [Related]

  • 60. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
    Descloux E, Durieu I, Cochat P, Vital Durand D, Ninet J, Fabien N, Cimaz R.
    Rheumatology (Oxford); 2008 Feb 01; 47(2):183-7. PubMed ID: 18160418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 155.